ER-positive, HER2-negative breast cancer accounts for approximately 72.7% of all breast cancer cases based on the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) data [4], but its pCR rate after NAC is less than 15% [2]. Here, ERBB2 is linked to breast carcinoma.